Pfizer PFE Deferred Revenue
Discontinued — last reported Q4 '25
Deferred Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Pfizer’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's deferred revenue?
- Pfizer (PFE) reported deferred revenue of $784M in Q4 2025.
- How has Pfizer's deferred revenue changed year-over-year?
- Pfizer's deferred revenue decreased by 48.1% year-over-year, from $1.51B to $784M.
- What is the long-term trend for Pfizer's deferred revenue?
- Over 5 years (2020 to 2025), Pfizer's deferred revenue has grown at a -6.8% compound annual growth rate (CAGR), from $1.11B to $784M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.